Physician profile
Christopher L Hunt
NPI 1558341255
$10,363.30
in general payments reported to CMS, 2019-2025
32 companies · $2,117 in 2025
The $2,117 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $483 · 2020: $280 · 2021: $748 · 2022: $1,508 · 2023: $2,265 · 2024: $2,962 · 2025: $2,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,254 · Education: $90.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,253.50 |
| Education | $90.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,322.97 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Medtronic, INC. | $1,558.62 | 2021-2025 | Intellis Adaptivestim, Vectris Surescan, Vanta Adaptivestim |
| Painteq LLC | $1,225.12 | 2022-2025 | Painteq |
| Nevro Corp. | $1,042.17 | 2019-2024 | Senza |
| Collegium Pharmaceutical, INC. | $537.98 | 2019-2025 | Xtampza, Belbuca |
| Curonix LLC | $200.12 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biotronik Nro, INC. | $194.30 | 2025 | Prospera |
| Globus Medical, INC. | $166.15 | 2025 | Vyrsa V1, Senza |
| Abbvie INC. | $145.16 | 2019-2025 | |
| Saluda Medical Americas, INC. | $141.70 | 2024-2025 | Evoke |
| Abbott Laboratories | $91.27 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $76.47 | 2019-2024 | |
| Pacira Therapeutics, INC. | $65.23 | 2019 | |
| Vertos Medical, INC. | $64.44 | 2022-2024 | Mild Device Kit |
| Tonix Medicines, INC. | $56.83 | 2025 | Tonmya |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $54.11 | 2020-2024 | Coolief* Cooled Radiofrequency |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.15 | 2020-2022 | |
| Almatica Pharma LLC | $45.86 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $44.57 | 2024-2025 | |
| Assertio Therapeutics, INC. | $38.85 | 2019 | |
| Biodelivery Sciences International, INC. | $38.22 | 2019-2021 | |
| Grt US Holding, INC. | $34.77 | 2021-2022 | |
| Merz Pharmaceuticals, LLC | $26.07 | 2023 | Xeomin |
| Convatec INC. | $25.59 | 2025 | |
| Spr Therapeutics, INC | $24.35 | 2024 | Sprint Pns System |
| Inari Medical, INC. | $16.04 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $15.01 | 2019 | |
| Pfizer INC. | $14.07 | 2020 | |
| Virtus Pharmaceuticals LLC | $13.86 | 2025 | Levorphanol Tartrate |
| Eagle Pharmaceuticals, INC. | $13.85 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $11.77 | 2019 | |
| Stimwave Technologies Incorporated | $11.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.